Cargando…

Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design

Broadly neutralizing antibodies (bNAbs) against HIV-1-Env V1V2 arise in multiple donors. However, atomic-level interactions had only been determined with antibodies from a single donor, making commonalities in recognition uncertain. Here we report the co-crystal structure of V1V2 with antibody CH03...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorman, Jason, Soto, Cinque, Yang, Max M., Davenport, Thaddeus M., Guttman, Miklos, Bailer, Robert T., Chambers, Michael, Chuang, Gwo-Yu, DeKosky, Brandon J., Doria-Rose, Nicole A., Druz, Aliaksandr, Ernandes, Michael J., Georgiev, Ivelin S., Jarosinski, Marissa C., Joyce, M. Gordon, Lemmin, Thomas M., Leung, Sherman, Louder, Mark K., McDaniel, Jonathan R., Narpala, Sandeep, Pancera, Marie, Stuckey, Jonathan, Wu, Xueling, Yang, Yongping, Zhang, Baoshan, Zhou, Tongqing, Mullikin, James C., Baxa, Ulrich, Georgiou, George, McDermott, Adrian B., Bonsignori, Mattia, Haynes, Barton F., Moore, Penny L., Morris, Lynn, Lee, Kelly K., Shapiro, Lawrence, Mascola, John R., Kwong, Peter D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833398/
https://www.ncbi.nlm.nih.gov/pubmed/26689967
http://dx.doi.org/10.1038/nsmb.3144
_version_ 1782427354013892608
author Gorman, Jason
Soto, Cinque
Yang, Max M.
Davenport, Thaddeus M.
Guttman, Miklos
Bailer, Robert T.
Chambers, Michael
Chuang, Gwo-Yu
DeKosky, Brandon J.
Doria-Rose, Nicole A.
Druz, Aliaksandr
Ernandes, Michael J.
Georgiev, Ivelin S.
Jarosinski, Marissa C.
Joyce, M. Gordon
Lemmin, Thomas M.
Leung, Sherman
Louder, Mark K.
McDaniel, Jonathan R.
Narpala, Sandeep
Pancera, Marie
Stuckey, Jonathan
Wu, Xueling
Yang, Yongping
Zhang, Baoshan
Zhou, Tongqing
Mullikin, James C.
Baxa, Ulrich
Georgiou, George
McDermott, Adrian B.
Bonsignori, Mattia
Haynes, Barton F.
Moore, Penny L.
Morris, Lynn
Lee, Kelly K.
Shapiro, Lawrence
Mascola, John R.
Kwong, Peter D.
author_facet Gorman, Jason
Soto, Cinque
Yang, Max M.
Davenport, Thaddeus M.
Guttman, Miklos
Bailer, Robert T.
Chambers, Michael
Chuang, Gwo-Yu
DeKosky, Brandon J.
Doria-Rose, Nicole A.
Druz, Aliaksandr
Ernandes, Michael J.
Georgiev, Ivelin S.
Jarosinski, Marissa C.
Joyce, M. Gordon
Lemmin, Thomas M.
Leung, Sherman
Louder, Mark K.
McDaniel, Jonathan R.
Narpala, Sandeep
Pancera, Marie
Stuckey, Jonathan
Wu, Xueling
Yang, Yongping
Zhang, Baoshan
Zhou, Tongqing
Mullikin, James C.
Baxa, Ulrich
Georgiou, George
McDermott, Adrian B.
Bonsignori, Mattia
Haynes, Barton F.
Moore, Penny L.
Morris, Lynn
Lee, Kelly K.
Shapiro, Lawrence
Mascola, John R.
Kwong, Peter D.
author_sort Gorman, Jason
collection PubMed
description Broadly neutralizing antibodies (bNAbs) against HIV-1-Env V1V2 arise in multiple donors. However, atomic-level interactions had only been determined with antibodies from a single donor, making commonalities in recognition uncertain. Here we report the co-crystal structure of V1V2 with antibody CH03 from a second donor and model Env interactions of antibody CAP256-VRC26 from a third. These V1V2-directed bNAbs utilized strand-strand interactions between a protruding antibody loop and a V1V2 strand, but differed in their N-glycan recognition. Ontogeny analysis indicated protruding loops to develop early, with glycan interactions maturing over time. Altogether, the multidonor information suggested V1V2-directed bNAbs to form an ‘extended class’, for which we engineered ontogeny-specific antigens: Env trimers with chimeric V1V2s that interacted with inferred ancestor and intermediate antibodies. The ontogeny-based design of vaccine antigens described here may provide a general means for eliciting antibodies of a desired class.
format Online
Article
Text
id pubmed-4833398
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-48333982016-06-21 Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design Gorman, Jason Soto, Cinque Yang, Max M. Davenport, Thaddeus M. Guttman, Miklos Bailer, Robert T. Chambers, Michael Chuang, Gwo-Yu DeKosky, Brandon J. Doria-Rose, Nicole A. Druz, Aliaksandr Ernandes, Michael J. Georgiev, Ivelin S. Jarosinski, Marissa C. Joyce, M. Gordon Lemmin, Thomas M. Leung, Sherman Louder, Mark K. McDaniel, Jonathan R. Narpala, Sandeep Pancera, Marie Stuckey, Jonathan Wu, Xueling Yang, Yongping Zhang, Baoshan Zhou, Tongqing Mullikin, James C. Baxa, Ulrich Georgiou, George McDermott, Adrian B. Bonsignori, Mattia Haynes, Barton F. Moore, Penny L. Morris, Lynn Lee, Kelly K. Shapiro, Lawrence Mascola, John R. Kwong, Peter D. Nat Struct Mol Biol Article Broadly neutralizing antibodies (bNAbs) against HIV-1-Env V1V2 arise in multiple donors. However, atomic-level interactions had only been determined with antibodies from a single donor, making commonalities in recognition uncertain. Here we report the co-crystal structure of V1V2 with antibody CH03 from a second donor and model Env interactions of antibody CAP256-VRC26 from a third. These V1V2-directed bNAbs utilized strand-strand interactions between a protruding antibody loop and a V1V2 strand, but differed in their N-glycan recognition. Ontogeny analysis indicated protruding loops to develop early, with glycan interactions maturing over time. Altogether, the multidonor information suggested V1V2-directed bNAbs to form an ‘extended class’, for which we engineered ontogeny-specific antigens: Env trimers with chimeric V1V2s that interacted with inferred ancestor and intermediate antibodies. The ontogeny-based design of vaccine antigens described here may provide a general means for eliciting antibodies of a desired class. 2015-12-21 2016-01 /pmc/articles/PMC4833398/ /pubmed/26689967 http://dx.doi.org/10.1038/nsmb.3144 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Gorman, Jason
Soto, Cinque
Yang, Max M.
Davenport, Thaddeus M.
Guttman, Miklos
Bailer, Robert T.
Chambers, Michael
Chuang, Gwo-Yu
DeKosky, Brandon J.
Doria-Rose, Nicole A.
Druz, Aliaksandr
Ernandes, Michael J.
Georgiev, Ivelin S.
Jarosinski, Marissa C.
Joyce, M. Gordon
Lemmin, Thomas M.
Leung, Sherman
Louder, Mark K.
McDaniel, Jonathan R.
Narpala, Sandeep
Pancera, Marie
Stuckey, Jonathan
Wu, Xueling
Yang, Yongping
Zhang, Baoshan
Zhou, Tongqing
Mullikin, James C.
Baxa, Ulrich
Georgiou, George
McDermott, Adrian B.
Bonsignori, Mattia
Haynes, Barton F.
Moore, Penny L.
Morris, Lynn
Lee, Kelly K.
Shapiro, Lawrence
Mascola, John R.
Kwong, Peter D.
Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
title Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
title_full Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
title_fullStr Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
title_full_unstemmed Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
title_short Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
title_sort structures of hiv-1-env v1v2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833398/
https://www.ncbi.nlm.nih.gov/pubmed/26689967
http://dx.doi.org/10.1038/nsmb.3144
work_keys_str_mv AT gormanjason structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT sotocinque structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT yangmaxm structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT davenportthaddeusm structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT guttmanmiklos structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT bailerrobertt structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT chambersmichael structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT chuanggwoyu structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT dekoskybrandonj structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT doriarosenicolea structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT druzaliaksandr structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT ernandesmichaelj structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT georgievivelins structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT jarosinskimarissac structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT joycemgordon structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT lemminthomasm structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT leungsherman structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT loudermarkk structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT mcdanieljonathanr structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT narpalasandeep structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT panceramarie structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT stuckeyjonathan structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT wuxueling structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT yangyongping structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT zhangbaoshan structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT zhoutongqing structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT mullikinjamesc structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT baxaulrich structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT georgiougeorge structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT mcdermottadrianb structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT bonsignorimattia structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT haynesbartonf structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT moorepennyl structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT morrislynn structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT leekellyk structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT shapirolawrence structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT mascolajohnr structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign
AT kwongpeterd structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign